BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

WOLVERINE ASSET MANAGEMENT LLC's Holding History (CIK: 0001279891)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 86,250,000 Value ($000) $97,079 Avg Close — Range —
Q3 2025
Shares 44,500,000 Value ($000) $44,009 Avg Close — Range —
Q2 2025
Shares 44,500,000 Value ($000) $41,638 Avg Close — Range —
Q1 2025
Shares 41,500,000 Value ($000) $37,284 Avg Close — Range —